期刊文献+

南方汉族等候肾移植终末期肾功能衰竭患者HLA基因多态性分析 被引量:9

Analysis of HLA polymorphisms in 3911 ESRD patients awaiting kidney transplantation
下载PDF
导出
摘要 目的对我国南方地区3911例等候肾脏移植的患者进行HLA-A,B,DRB1基因表达的回顾性研究,以探讨在因肾脏疾病导致患者最终并发终末期肾功能衰竭(ESRD)进程中的HLA免疫遗传易感性及其相对风险作用。方法采用聚合酶链反应-序列特异性引物扩增(PCR-SSP)技术进行HLA-A,B,DR基因分型,应用SPPS13.0软件包统计分析ESRD患者中HLA抗原频率、基因频率、HLA-A,B,DR三个位点的单倍型频率(HF)、连锁不平衡参数、相对危险度(RR)及优势比(OR)。结果ESRD患者中表达出HLA-A抗原19个,HLA-B抗原40个,HLA-DR抗原14个;其中呈现抗原频率显著增高(PC<0.0001,PC值即P值乘以所检测的某一位点的抗原数)的是HLA-B75(RR=1.222,OR=1.479)、DR4(RR=1.146,OR=1.294),DR17(RR=1.541,OR=2.639);呈现出抗原频率显著降低(PC<0.0001)的是HLA-DR8(RR=0.812,OR=0.697)、DR9(RR=0.878,OR=0.793);ESRD患者中具有显著连锁不平衡单倍型(HF>0.5%)10条,分别为A1-B37-DR10,A2-B7-DR17,A29-B7-DR10,A30-B13-DR7,A33-B13-DR17,A33-B44-DR17,A33-B46-DR17,A33-B58-DR17,A33-B60-DR17和A33-B75-DR17,其中A33-B75-DR17、A33-B58-DR17频率高达7.93%和11.74%。结论研究发现HLA-B75、DR4和DR17可能对南方地区肾脏疾病患者最终并发ESRD具有独立易感关联,而表达HLA-DR8、DR9的肾脏病患者将可能不易并发ESRD;单倍型A33-B75-DR17高频率出现说明HLA-B75,DR17不仅具有独立易感作用还可能对肾脏病患者最终并发ESRD具有集合易感作用。这个发现对于等候肾脏移植患者选择合适供体以提高移植后患者生存时间和远期移植效果具有临床指导意义。 Objective The expression of HLA-A,B and DRB1 alleles of end-stage renal disease (ESRD) patients awaiting kidney transplantation, in Southern Chinese Han population was analysed in order to explore HLA polymorphisms as immune and genetic factors in the pathogenesis of ESRD. Methods DNA was extracted by salting-out method. Poly-merase chain reaction-sequence specific primer(PCR-SSP) were used to analyze the type of HLA-A , B and DRB1 alleles of 3 911 ESRD patients. The phenotype frequencies, gene frequencies,haplotypes frequencies, relative risk(RR ), and odd ratio (OR) were calculated with a statistic software named SPSS13.0. Results 19 HLA-A,40 HLA-B,and 14 HLA-DR were detected in 3911 patients. The antigens HLA-B75 (RR = 1. 222 and OR = 1. 479), HLA-DR4 ( RR = 1. 149 and OR = 1. 294) and HLA-DR17 (RR = 1. 541 and OR=2. 639)) were at significantly higher frequencies among patients compared with controls. However, the antigens, HLA-DR8 (RR = 0. 812 and OR = 0. 697) and HLA-DR9 (RR = 0. 878 and OR = 0. 793) were at a significantly lower frequency among patients. There were 10 haplotypes with significant linkage disequilibrium observed in ESRD patients, of which the frequencies were more than 0. 005, including A1-B37-DR10, A2-B7-DR17, A29-B7-DR10, A30-B13-DR7, A33-B13- DR17 ,A33-B44-DR17,A33-B46-DR17, A33-B58-DR17,A33-B60-DR17and A33-B75-DR17. The haplotype A33-B75-DR17 and A33-B58-DR17 showed a frequency of 7.93% and 11.74% respectively. Conclusions The susceptible HLA antigens in patients with renal diseases complicated with ESRD were HLA-B75, DR4, and DR17 in Southern China, while the protective ones were HLA-DR8 and DR9. The haplotype A33-B75-DR17 showed high frequency , indicating HLA-B75, DR17 are not only the independent susceptible genes but also the compound susceptible ones. The founding were helpful for ESRD patients awaiting kidney transplantation to choose suitable donors in order to increase their survival time and improve efficacy of transplantation in a long time.
出处 《现代泌尿外科杂志》 CAS 2010年第2期110-113,共4页 Journal of Modern Urology
基金 广东省自然科学团队基金资助项目(No.23003)
关键词 终末期肾功能衰竭 人类白细胞抗原 基因多态性 end-stage renal disease human leucocyte antigen gene polymorphisms
  • 相关文献

参考文献10

  • 1吴国光,邓志辉,高素青,程良红,金士正,周丹,李桢,邹红岩,张旋,魏天莉,程曦,王大明.6965名汉族骨髓供者HLA多态性分析[J].中华血液学杂志,2004,25(8):473-477. 被引量:96
  • 2PAPASAVAS EC, SPYROPOULOU-VLACHOU M, PAPASAVAS ACH, et al. MHC class Ⅰ and class Ⅱ phenotype, gene and haplotype frequencies in Greeks using molecular typingdata. [J]. Hum Immuno, 2000,61(6) :615-623.
  • 3CAILLAT-ZUCMAN S. Molecular mechanisms of HLA association with autoimmune diseases[J]. Tissue Antigens, 2009, 73 (1) : 1-8.
  • 4DOXIADIS IIN, LANGE P DE, VRIES E DE, et al. Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure[J]. Tissue Antigens, 2001,57(4) : 344- 347.
  • 5SPRIEWALD BM, WITZKE O, WASSUMUTH R, et al. Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis[J]. Ann Rheum Dis,2005,64(3) :446-457.
  • 6CRISPIM J C, MENDES-JUNIOR C T, WASTOWSKI I J, et al. HLA polymorphisms as incidence factor in the progression to endstage renal disease in Brazilian patient awaiting kidney transplant [J]. Transplant Proc,2008,40(5) : 1333-1336.
  • 7PEREZ-LUQUE E, MALACARA J M, OLIVO-DIAZ A, et al. Contribution of HLA class Ⅱ genes to end stage renal disease in mexican patients with type 2 diabetes mellitus[J]. Hum Immunol, 2000,61(10) : 1031-1038.
  • 8KARAHAN G E, SEYHUN Y, OGUZ F S, et al. Impact of HLA on the underlying primary diseases in Turkish patients with endstage renal disease[J]. Ren Fail,2009,31(1):44-49.
  • 9ALVAREZ I, COLLADO J, DAURA X, ct al. The rheumatoid arthritis-associated allele HLA-DR10 (DRB1 * 1001) shares part of its repertoire with HLA-DR1 (DRB1 * 0101 ) and HLA-DR4 (DRB * 0401) [J]. Arthritis Rheum, 2008,58(6) : 1630-1639.
  • 10KAPITANY A, SZABOZ, LAKOS G, et al. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis[J]. Isr Med Assoc J,2008,10(1) :32-38.

二级参考文献8

  • 1Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2002. Hum Immunol, 2002, 63:1213-1268.
  • 2Tiercy JM, Marsh SG, Schreuder GM, et al. Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes. Eur J Immunogenet, 2002, 29:273-274.
  • 3Schreuder GM, Hurley CK, March SG, et al. The HLA dictionary 2001:a summary of HLA-A,-B,-C, DRB1/3/4/5,-DQB1 alleles and their association with serologically defined HLA-A,-B,-C,-DR and -DQ antigens. Hum Immunol, 2001,62 : 826-849.
  • 4Wu GG, Cheng LH, Deng ZH, et al. Cloning and complete sequence of a novel HLA-A null allele, A * 0253N, with a termination codon generated by a C to G mutation in exon 2. Tissue Antigens, 2002, 59: 328-330.
  • 5Wu GG, Cheng LH, Li Z, et al. Identification of a new HLA allele, A * 1114, in a Chinese family. Tissue Antigens, 2003, 61:253-255.
  • 6Wu GG, Cheng LH, Zhou D, et al. Identification of a novel allele HLA-B * 5610 in a Chinese potential bone marrow donor.Tissue Antigens, 2003, 61: 256-258.
  • 7Hurley CK, Maiers M, Ng J, et al. Large-scale DNA-based typing for HLA-A and HLA-B at low resolution is highly accurate specific and reliable. Tissue Antigens, 2000,55:352-358.
  • 8Bunce M, O'Neil CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3,DRB4, DRB5 &amp; DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens, 1995,46: 355-367.

共引文献95

同被引文献116

引证文献9

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部